CoChat

Invasive Candidiasis: Turning Risk into a Practical Prevention Policy?

Sobel, Jack D., Rex, John H. · 2001 · Clinical Infectious Diseases
Cited by 73

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

For 3 decades, systemic antifungal use was virtually a 1-drug act—amphotericin B. Administration of antifungal agents to critically ill patients was dominated by fear of toxicity rather than knowledge of its efficacy. In the past decade, the availability of azole antifungal agents with enhanced pharmacokinetic and safety profiles completely revolutionized systemic antifungal use. If anything, their arrival caught clinicians unprepared, and guidelines for the optimal use of triazoles lagged behind common practice utilization. Use of azole drugs in the surgical intensive care unit (SICU) has become an established fact of life, with use unimpeded by the slow development or, in many areas, complete absence of useful data. In the meantime, the frequency of invasive, often life-threatening candidal infections has increased dramatically [1, 2], largely as a function of medical technological advances (e.g., vascular catheters, total parenteral nutrition [TPN], hemodialysis) and the enhanced ability of clinicians to keep critically ill patients alive. Much early attention was focused on patients with neutropenia, and considerable progress has been made in validating the efficacy of antifungal prophylaxis and conducting prospective, randomized, controlled trials that support the use of antifungal agents for the treatment of persistently febrile patients with neutropenia who do not respond to antibiotics [3, 4]. These 2 policies have resulted in control of and actual reduction in the frequency of bloodstream infections (BSIs) due to Candida species and systemic candidiasis in patients with neutropenia. Now attention has turned toward patients without neutropenia. In fact, most BSIs due to Candida species now occur in patients who have been hospitalized in intensive care units (ICUs), especially adult SICUs and neonatal ICUs. Moreover, throughout the world, the dominance of Candida albicans has been challenged by the increased prevalence of serious infection caused by non-albicans Candida species. Candida species are now the fourth most common bloodstream isolates, following coagulase-negative staphylococci, Staphylococcus aureus, and enterococci [5–7]. Although BSIs caused by Candida species continue to be the primary end point in observational and interventional studies, invasive candidal infections that involve the abdominal cavity, bone, soft tissue, or other sites are no less important and are responsible for considerable morbidity and death. Several retrospective studies have identified multiple risk factors for candidal BSI in patients in the ICU [8–14]. Most of the risk factors have been repeatedly verified, although others are more controversial. Major risk factors include use of central venous catheters, TPN, receipt of multiple antibiotics, extensive surgery and burns, renal failure and hemodialysis, mechanical ventilation, and prior fungal colonization. In addition to these data, we now have the findings of Blumberg et al. [15] from a detailed prospective evaluation of risk factors for candidal BSI, performed under the auspicies of the National Epidemiology of Mycoses Survey (NEMIS). In the NEMIS study [15], data were collected prospectively from 6 SICUs in the United States. Forty-two BSIs in 4276 patients were identified during a 2-year period. Once again, the dominant risk factors were prior surgery (RR, 7.3), acute renal failure (RR, 4.2), and TPN (RR, 3.6), with a significant trend toward candidal BSI developing in association with shock, disseminated intravascular coagulation, and adult respiratory distress syndrome. Other important findings included the contributory role of the triple-lumen catheter in surgical patients. A key additional analysis demonstrated that not all patients in the SICU are at equal risk of invasive candidiasis. Of note, patients who undergo neurosurgical or ear, nose, and throat procedures appear to be at the lowest risk, followed by orthopedic and gynecologic patients. As multiple previous studies have shown, abdominal surgery proved to be the highest risk. Neither corticosteroid use, a controversial risk factor for candidemia, nor severity of illness (as measured by acute physiology and chronic health evaluation II scores [16]) emerged as a contributory factor in the study. Even more interesting is that colonization with Candida species was also not found to be an independent risk factor for candidal BSI. In the NEMIS study, weekly rectal and urinary surveillance cultures were performed. The positive predictive value of colonization was <3%. The latter observation is in contrast to the findings of several previous studies in which colonization was linked to risk of candidemia [8–10]. The cause of this difference may be the design of the studies. Wey et al. [8] and Bross et al. [9] used a case-control design, whereas Pittet et al. [10] studied relative degrees of colonization among a highly selected group of at-risk patients. The NEMIS study, on the other hand, included a ver

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/321812

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

Metadata

Authors
Sobel, J. D., & Rex, J. H.
Venue
Clinical Infectious Diseases
Published
2001-07-15
Volume
33
Issue
2
Pages
187-190
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2103915504
Cited by
73
References
9
FWCI
5.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.